Saskia K. Klein
Saskia K. Klein publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research and Cancer Treatment and Pharmacology.
- World rank
- #842,929 of 7,710,434 ranked researchers
- Rank in Netherlands
- #19,974 of 107,149
- Works
- 128
- Citations
- 4.2k
- Citations per work
- 32.9
What does Saskia K. Klein research?
Saskia K. Klein's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6651.5%
- Medicine6651.5%
- Everything else3729.2%
- Life Sciences2519.3%
- 1Hematology30% of their works
- 2Molecular Biology15% of their works
- 3Oncology11% of their works
- 4Genetics6% of their works
- 5Immunology4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Cancer Treatment and Pharmacology
- Protein Degradation and Inhibitors
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Histone Deacetylase Inhibitors Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Saskia K. Klein's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors, Acute Myeloid Leukemia, AML, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and BET Bromodomains.
- JAK2 Mutation
- HDAC Inhibitors
- BCR-ABL
- Chronic Lymphocytic Leukemia
- BET Bromodomains
- Chemotherapy-Induced Peripheral Neuropathy
- AML
- International Myeloma Working Group
- Diagnosis Criteria
- Prognostic Factors
- Acute Myeloid Leukemia
- Taxanes
- PROTACs
- Genomic Aberrations
- Imatinib
- Histone Deacetylases
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Diagnosis Criteria561 topic
- International Myeloma Working Group561 topic
- Prognostic Factors432 topics
- AML311 topic
- Acute Myeloid Leukemia311 topic
- Chemotherapy-Induced Peripheral Neuropathy291 topic
- Taxanes291 topic
- BET Bromodomains201 topic
- PROTACs201 topic
- Chronic Lymphocytic Leukemia121 topic
- Genomic Aberrations121 topic
- BCR-ABL111 topic
- Imatinib111 topic
- HDAC Inhibitors91 topic
- Histone Deacetylases91 topic
- JAK2 Mutation81 topic
- Myelofibrosis81 topic
Where does Saskia K. Klein work?
Saskia K. Klein's main affiliation in the publication record is Meander Medisch Centrum, Netherlands.
How many publications and citations does Saskia K. Klein have?
OpenAlex counts 128 works and 4,212 citations for Saskia K. Klein, an h-index of 27, ranking #842,929 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Saskia K. Klein. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.